MapLight Therapeutics is the latest biotech to want a turn with Alphabet’s AI spinout SandboxAQ. | MapLight Therapeutics is ...
Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...
Secondary CNS lymphoma happens when non-Hodgkin’s lymphoma spreads to the brain, spinal cord, or eyes. Its symptoms depend on the areas of the CNS that are affected. The outlook for people with this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback